Annual report pursuant to Section 13 and 15(d)

Stockholders??? Deficit (Tables)

v3.25.0.1
Stockholders’ Deficit (Tables)
 12 Months Ended
Dec. 31, 2023
Equity [Abstract]  
Schedule of Stockholders’ Deficit

The following table summarizes the activity in the Company’s various classes of preferred stock included in Stockholders’ Deficit for the years ended December 31, 2023 and 2022:

 

    Shares     Amount     Shares     Amount     Shares     Amount     Shares     Amount     Shares     Amount     Shares     Amount     Shares     Amount  
    Series H      Series L     Series M     Series N     Series O     Series P     Total  
    Shares     Amount     Shares     Amount     Shares     Amount     Shares     Amount     Shares     Amount     Shares     Amount     Shares     Amount  
Balance December 31, 2022     10     $ - - 250,000     $ 2,500       20,810     $ 208       2,900     $ 29       8,685     $ 87       10,195     $ 102       292,600     $ 2,926  
Conversions of Series N Preferred Stock into common stock     -       -       -       -       -               (496 )     (5 )     -       -       -       -       (496 )     (5 )
Conversions of Series O Preferred Stock into common stock     -       -       -       -       -       -       -       -       (535 )     (5 )     -       -       (535 )     (5 )
Balance December 31, 2023     10     $ -   - 250,000     $ 2,500       20,810     $ 208       2,404     $ 24       8,150     $ 82       10,195     $ 102       291,569     $ 2,916  

 

    Shares     Amount     Shares     Amount     Shares     Amount     Shares     Amount     Shares     Amount     Shares     Amount     Shares     Amount     Shares     Amount  
    Series H     Series F     Series L     Series M     Series N     Series O     Series P     Total  
    Shares     Amount     Shares     Amount     Shares     Amount     Shares     Amount     Shares     Amount     Shares     Amount     Shares     Amount     Shares     Amount  
Balance December 31, 2021     10     $ -       1,750,000     $ 17,500       250,000     $ 2,500       20,810     $ 208       5,936     $ 59       9,900     $ 99       8,545     $ 85       2,045,201     $ 20,451  
Conversion of Series F Preferred Stock into common stock     -       -       (1,750,000 )     (17,500 )     -       -       -       -       -       -               -       -       -       (1,750,000 )     (17,500 )
Issuances of Series P Preferred Stock     -       -       -       -       -       -       -       -       -       -       -       -       1,650       17       1,650       17  
Conversions of Series N Preferred Stock into common stock     -       -       -       -       -       -       -               (3,036 )     (30 )     -       -       -       -       (3,036 )     (30 )
Conversions of Series O Preferred Stock into common stock     -       -       -       -       -       -       -       -       -       -       (1,215 )     (12 )     -       -       (1,215 )     (12 )
Balance December 31, 2022     10     $ -       -     $ -       250,000     $ 2,500       20,810     $ 208       2,900     $ 29       8,685     $ 87       10,195     $ 102       292,600     $ 2,926  
Schedule of Stock Option Activity

   

Number of

options

    

Weighted-

average

exercise price

    

Weighted-

average

contractual term (years)

  
Outstanding at December 31, 2021     26     $ 2,992,125       4.33  
Granted     -                  
Expired     -                  
Outstanding at December 31, 2022     26     $ 2,992,125       3.37  
Granted     -                  
Expired     -                  
Outstanding at December 31, 2023     26     $ 2,992,125       2.37  
                         
Exercisable at December 31, 2023     26     $ 2,992,125          
Schedule of Stock Option Outstanding and Exercisable

The following table summarizes information with respect to stock options outstanding and exercisable by employees and directors at December 31, 2023:

 

Options outstanding     Options vested and exercisable  
Exercise price     Number outstanding     Weighted average remaining contractual life (years)     Weighted average exercise price     Aggregate intrinsic value     Number vested     Weighted average exercise price     Aggregate intrinsic value  
$ 10,000,000       5       2.25     $ 10,000,000     $ -       5     $ 10,000,000     $ -  
$ 5,000,000       5       2.25     $ 5,000,000       -       5     $ 5,000,000       -  
$ 269,580       8       2.33     $ 269,580       -       8     $ 269,580       -  
$ 80,906       8       2.54     $ 80,906       -       8     $ 80,906       -  
          26       2.37     $ 2,992,125     $ –       26     $ 2,992,125     $ -  
Schedule of Warrants Activity

The following summarizes the information related to the number of shares of common stock issuable under outstanding warrants during the years ended December 31, 2023 and 2022:

 

   

Number of Shares of

Common Stock Issuable
for Warrants

    

Weighted

average exercise
price

  
Balance at December 31, 2021                               54,280,658     $ 1.43  
Issuance of warrants     -       -  
Increase in number of shares of common stock issuable under
warrants during the period as a result of down round provisions		     511,312,671,643       -  
Expiration of warrants     (33,601,211 )     (0.9141 )
Balance at December 31, 2022     511,333,351,090     $ 0.00009  
Issuance of warrants     -       -  
Expiration of warrants     (1 )     (794,998 )
Balance at December 31, 2023     511,333,351,089     $ 0.00009